First Republic Investment Management, Inc. Ironwood Pharmaceuticals Inc Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$10.16 - $13.11 $199,268 - $257,126	-19,613 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$9.04 - $11.86 $38,772 - $50,867	-4,289 Reduced 17.94%	19,613 $219,000
Q4 2020 Feb 16, 2021	BUY	$9.05 - $12.2 $2,615 - $3,525	289 Added 1.22%	23,902 $272,000
Q1 2020 May 13, 2020	SELL	$8.58 - $14.01 $34,320 - $56,040	-4,000 Reduced 14.49%	23,613 $238,000
Q4 2019 Feb 14, 2020	SELL	$8.22 - $14.0 $74,284 - $126,518	-9,037 Reduced 24.66%	27,613 $368,000
Q3 2019 Nov 08, 2019	BUY	$8.59 - $10.96 $1,125 - $1,435	131 Added 0.36%	36,650 $315,000
Q1 2019 Apr 30, 2019	SELL	$8.27 - $12.73 $1.2 Million - $1.85 Million	-145,533 Reduced 79.94%	36,519 $494,000
Q3 2018 Nov 13, 2018	SELL	$14.31 - $17.65 $71,550 - $88,250	-5,000 Reduced 2.67%	182,052 $3.36 Million
Q2 2018 Aug 14, 2018	BUY	$11.83 - $16.2 $1.92 Million - $2.62 Million	161,994 Added 646.48%	187,052 $3.58 Million
Q1 2018 May 10, 2018	SELL	$11.13 - $13.63 $111,300 - $136,300	-10,000 Reduced 28.52%	25,058 $387,000
Q4 2017 Feb 09, 2018	BUY	$12.16 - $14.58 $426,305 - $511,145	35,058	35,058 $526,000

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

Black Rock Inc. New York, NY

22.9M
Shares

$96.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

22M
Shares

$92.8 Million
0.0% of portfolio
Sarissa Capital Management LP Greenwich, CT

16.4M
Shares

$69 Million
16.75% of portfolio
Pacer Advisors, Inc. Malvern, PA

11.3M
Shares

$47.5 Million
0.11% of portfolio
State Street Corp Boston, MA

9.92M
Shares

$41.8 Million
0.0% of portfolio

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $645M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account